Shifa Institute Of Medical Science Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 27-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 27-06-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 5.00 Cr
as on 27-06-2024
- Revenue -12.35%
(FY 2020)
- Profit 150.92%
(FY 2020)
- Ebitda 202.65%
(FY 2020)
- Net Worth 0.64%
(FY 2020)
- Total Assets -15.23%
(FY 2020)
About Shifa Institute Of Medical Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹5.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Cathirikanakka Ayshakutty and Alikkath Muhammedhaneefa serve as directors at the Company.
- CIN/LLPIN
U85110KL2012PTC030298
- Company No.
030298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shifa Institute Of Medical Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alikkath Muhammedhaneefa  | Managing Director | 19-Jan-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Cathirikanakka Ayshakutty | Director | 19-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Shifa Institute Of Medical Science.
Shifa Institute Of Medical Science Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.35% decrease. The company also saw a substantial improvement in profitability, with a 150.92% increase in profit. The company's net worth moved up by a moderate rise of 0.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shifa Institute Of Medical Science?
In 2020, Shifa Institute Of Medical Science had a promoter holding of 64.00% and a public holding of 36.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 16 May 2015 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Shifa Institute Of Medical Science?
Unlock and access historical data on people associated with Shifa Institute Of Medical Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shifa Institute Of Medical Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shifa Institute Of Medical Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
